Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Oxycontin: America’s next new export

Ankur Dave, MD
Meds
January 26, 2017
392 Shares
Share
Tweet
Share

The health care system has been devastated by the opioid epidemic. Addictive opiate medications have not been shown to benefit patients with chronic pain, yet they are the most prescribed pills in the United States.

As a pain management physician, I have seen opiates, when in the wrong hands, destroy lives. As doctors and health care organizations scramble to treat more than 2 million Americans suffering from opioid addiction, drug companies look to expand their brand. Recently, Mundipharma, a global network of pharmaceutical corporations, began a worldwide marketing campaign for Oxycontin, the drug at the heart of America’s opioid crisis. If they are allowed to succeed, America’s opioid epidemic may quickly become our main export.

Opiates have a muddied history in American health care. For years, these drugs, such as morphine, were only used for acute and end-of-life pain but otherwise avoided due to powerfully addictive tendencies. People suffered from chronic pain but had no options. Thus, there has always been a need for a “non-addictive” pain medication.

In the early 1900s, heroin was introduced as that miracle drug. The nation watched in shock as prescription heroin unleashed a medication epidemic. In the 1990s, the mistake was repeated when Purdue Pharmaceuticals released Oxycontin. The results were much worse because Purdue unleashed a marketing campaign never before seen in healthcare.

Oxycontin was specifically advertised as the miracle “non-addictive” opiate medication. Purdue either leveraged physicians into leadership roles or silenced critics with threats of lawsuits. Purdue lobbied politicians and medical organizations to support regulations pressuring doctors to prescribe opiates for chronic pain. They even started marketing to patients; a concept never before used in healthcare. Purdue’s aggressive campaign, based on a lie, made Oxycontin the first billion-dollar drug.

The truth is, Purdue knew Oxycontin was powerfully addictive. In 2007, they were found guilty of misbranding and ordered to pay $600 million. By then, the damage was done. Over 500,000 Americans have died from opioid-related causes, and more than 75 people die every day. Chronic pain is the most common reason patients visit their primary care physicians, yet most doctors feel inadequately trained in safely managing this condition. I see patients every day with chronic pain; it is debilitating, and many are desperate for answers. Unfortunately, most patients are woefully uneducated about their condition and treatment options. The biggest challenges are correcting the misconceptions that chronic pain is completely curable and pills make people pain-free, especially when amplified by marketing campaigns. This mindset drives patients towards opiates and is the main obstacle in ending the opioid epidemic.

Despite Oxycontin’s devastating effects, Mundipharma, whose group includes Purdue Pharmaceuticals, is using the same strategies worldwide that resulted in Purdue’s lawsuit. Doctors in China and Brazil are urged to overcome “opiophobia” and patients are given discounts for opiates. Commercials in Spain show individuals struggling with and then overcoming chronic pain with the help of Mundipharma’s drugs. Mundipharma’s lobbyists are even urging foreign governments to aggressively reform their opiate prescribing policies.

This is the same formula that led to America’s opioid epidemic. International chronic pain patients are desperate for an answer. They are unaware of the 25 percent addiction rate for Americans on chronic opiates or that patients from Purdue’s “Swinging in the Right Direction with Oxycontin” commercial swung right into addiction. They simply want to feel better.

It is not just patients. Physicians worldwide are not prepared for opioid management. Opiates have never been part of their treatment plans, and now patients are coming to their clinics and asking for these pills. Many countries do not even have the screening tools to manage opioid therapy let alone the basic resources for substance use disorders.

Chronic pain is a tough condition, and I empathize with my patients. Most are hard-working people who just want to care for their loved ones. Some have become addicted to opiates, but many have not. Regardless, they are all victims of the opioid epidemic. Companies like Purdue took advantage of them.

Now, physicians like myself are left to pick up the shambles of opiate misuse and redefine our approach to chronic pain. Like locusts, Mundipharma has consumed our most valuable resource, our people, and are now finding new victims. As Americans, we have seen the destruction opioids can cause if not carefully regulated. Other countries are not prepared for what is headed their way. We are looking at the globalization of Oxycontin, one of the world’s most addictive prescription pills. We are already battling an opioid epidemic: We do not have the resources for a global pandemic.

Ankur Dave is a pain management specialist.

Image credit: Shutterstock.com

Prev

A gift of homemade food is the ultimate gift of love

January 25, 2017 Kevin 4
…
Next

What are the ethics of health care reform?

January 26, 2017 Kevin 1
…

Tagged as: Medications

Post navigation

< Previous Post
A gift of homemade food is the ultimate gift of love
Next Post >
What are the ethics of health care reform?

Related Posts

  • 5 hidden consequences of chronic pain

    Toni Bernhard, JD
  • 5 things I wish I had known earlier about chronic pain

    Tom Bowen
  • Using low-dose naltrexone to treat pain

    Alex Smith
  • Blame the pain, not the opioids

    Angelika Byczkowski
  • On the internet, you are looking for something to make you angry

    Judson Ellis
  • 10 challenges faced by those with chronic pain and illness

    Toni Bernhard, JD

More in Meds

  • From Moscow Mule to the opioid crisis: Unveiling the tragic legacy and urgent solutions

    Osmund Agbo, MD
  • The deadly consequences of a shortage: The Pluvicto crisis leaves metastatic prostate cancer patients in limbo

    Matt Drewes
  • The real story of Xylazine contamination in street fentanyl and how we can manage it

    Julie Craig, MD
  • The cannabis education gap: Why patients are left in the dark

    Timothy Byars
  • Are doctors ready to discuss psychedelic therapies with patients?

    Thaís Salles Araujo, MD
  • The rise and dark side of fungi: Exploring health benefits and pathogenic threats

    Sandra Vamos, EdD and Deanna Lernihan, MPH
  • Most Popular

  • Past Week

    • A physician’s typical day, as envisioned by a non-clinician health care MBA: a satire

      Jennifer Lycette, MD | Physician
    • Is chaos in health care leading us towards socialized medicine? How physician burnout is a catalyst.

      Howard Smith, MD | Physician
    • Revealing America’s expansion: the dark truth of Native American suffering and unjustified abuses

      Anonymous | Physician
    • The tragic story of Mr. G: a painful journey towards understanding suicide

      William Lynes, MD | Physician
    • The rising threat of lung cancer in Asian American female nonsmokers

      Alice S. Y. Lee, MD | Conditions
    • From Moscow Mule to the opioid crisis: Unveiling the tragic legacy and urgent solutions

      Osmund Agbo, MD | Meds
  • Past 6 Months

    • “Is your surgeon really skilled? The hidden threat to public safety in medicine.

      Gene Uzawa Dorio, MD | Physician
    • Breaking the cycle of racism in health care: a call for anti-racist action

      Tomi Mitchell, MD | Policy
    • Unveiling the hidden damage: the secretive world of medical boards

      Alan Lindemann, MD | Physician
    • An inspiring tribute to an exceptional radiologist who made a lasting impact

      Kim Downey, PT | Conditions
    • The hidden factor in physician burnout: How the climate crisis is contributing to the erosion of well-being

      Elizabeth Cerceo, MD | Physician
    • Proactive risk management: a game-changer in preventing physician burnout

      Howard Smith, MD | Physician
  • Recent Posts

    • Physician employment contracts: the key to fighting burnout and improving working conditions [PODCAST]

      The Podcast by KevinMD | Podcast
    • A tense family drama unfolds as a young daughter pursues unconventional career path

      Osmund Agbo, MD | Physician
    • Decoding the brain’s decision-making: insights for medical professions and strategies for success

      Harvey Castro, MD, MBA | Physician
    • Unmasking the truth: the shocking reality of the opioid epidemic and who’s really to blame

      Jay K. Joshi, MD | Physician
    • Discover your true north: Navigating life’s confusions and embracing your path to success

      Tyler Jorgensen, MD | Physician
    • A revolution in patient empowerment: Working together to save our medical system [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Insomnia Symptoms Tied to Stroke a Decade Later
  • Studies Question Role of CDK4/6 Inhibitors in First-Line Advanced Breast Cancer
  • Full-On Reversal of Cardiac Amyloidosis Possible With Antibodies
  • Spell Check-Up: Do You Have the Skills to Pass This Spelling Test?
  • For Some, Sex Is Better Sleep Aid Than Pill, Small Survey Finds

Meeting Coverage

  • Studies Question Role of CDK4/6 Inhibitors in First-Line Advanced Breast Cancer
  • For Some, Sex Is Better Sleep Aid Than Pill, Small Survey Finds
  • Skipping Radiotherapy 'Seems Safe' for PMBCL Patients in Remission
  • Promising Gene Therapy for Overactive Bladder
  • Shotgun Sequencing of Small Intestine Reveals Species Tied to GI Symptom Severity
  • Most Popular

  • Past Week

    • A physician’s typical day, as envisioned by a non-clinician health care MBA: a satire

      Jennifer Lycette, MD | Physician
    • Is chaos in health care leading us towards socialized medicine? How physician burnout is a catalyst.

      Howard Smith, MD | Physician
    • Revealing America’s expansion: the dark truth of Native American suffering and unjustified abuses

      Anonymous | Physician
    • The tragic story of Mr. G: a painful journey towards understanding suicide

      William Lynes, MD | Physician
    • The rising threat of lung cancer in Asian American female nonsmokers

      Alice S. Y. Lee, MD | Conditions
    • From Moscow Mule to the opioid crisis: Unveiling the tragic legacy and urgent solutions

      Osmund Agbo, MD | Meds
  • Past 6 Months

    • “Is your surgeon really skilled? The hidden threat to public safety in medicine.

      Gene Uzawa Dorio, MD | Physician
    • Breaking the cycle of racism in health care: a call for anti-racist action

      Tomi Mitchell, MD | Policy
    • Unveiling the hidden damage: the secretive world of medical boards

      Alan Lindemann, MD | Physician
    • An inspiring tribute to an exceptional radiologist who made a lasting impact

      Kim Downey, PT | Conditions
    • The hidden factor in physician burnout: How the climate crisis is contributing to the erosion of well-being

      Elizabeth Cerceo, MD | Physician
    • Proactive risk management: a game-changer in preventing physician burnout

      Howard Smith, MD | Physician
  • Recent Posts

    • Physician employment contracts: the key to fighting burnout and improving working conditions [PODCAST]

      The Podcast by KevinMD | Podcast
    • A tense family drama unfolds as a young daughter pursues unconventional career path

      Osmund Agbo, MD | Physician
    • Decoding the brain’s decision-making: insights for medical professions and strategies for success

      Harvey Castro, MD, MBA | Physician
    • Unmasking the truth: the shocking reality of the opioid epidemic and who’s really to blame

      Jay K. Joshi, MD | Physician
    • Discover your true north: Navigating life’s confusions and embracing your path to success

      Tyler Jorgensen, MD | Physician
    • A revolution in patient empowerment: Working together to save our medical system [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Oxycontin: America’s next new export
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...